Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)

References

• Kelly P., Shapiro B. Amyotrophic lateral sclerosis and other motor neuron disorders. Principles of Neuroepidemiology, T Batchelor, M Cudkowicz. Butterworth‐Heinemann, Woburn 2001; 265–88
   Google Scholar
• Kurtzke J. F. Risk factors in amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 245–70
   PubMedGoogle Scholar
• Mitchell J. D., Davies R. B., al‐Hamad A., Gatrell A. C., Batterby G. MND risk factors: an epidemiological study in the north‐west of England. J Neurol Sci 1995; 129(Suppl.)61–4
   PubMedGoogle Scholar
• Armon C., Kurland L., Daube J., O'Brien P. Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology 1991; 41: 1077–84
   PubMed Web of Science ®Google Scholar
• Armon C. An evidence‐based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 2003; 22: 217–28
   PubMed Web of Science ®Google Scholar
• Swash M. Clinical features and diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, R Jr Brown, V Meininger, M Swash. Martin Dunitz Ltd, London 2000; 3–30
   Google Scholar
• Nelson L. Epidemiology of ALS. Clin Neurosci 1996; 3: 327–31
   Google Scholar
• Nelson L., Matkin C., Longstreth W., McGuire V. Population‐based case‐control study of amyotrophic lateral sclerosis in western Washington state. II. Diet. Am J Epidemiol 2000; 151: 164–73
   PubMed Web of Science ®Google Scholar
• Nelson L., McGuire V., Longstreth WT. Jr., Matkin C. Population‐based case‐control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 2000; 151: 156–63
   PubMed Web of Science ®Google Scholar
• Armon C. Environmental risk factors for amyotrophic lateral sclerosis. Neuroepidemiology 2001; 20: 2–6
   PubMed Web of Science ®Google Scholar
• Chio A. Risk factors in the early diagnosis of ALS: European epidemiological studies. ALS and Other Motor Neuron Disorders 2000; 1((Suppl. 1))S13–8
   PubMedGoogle Scholar
• Brooks B. Clinical epidemiology of amyotrophic lateral sclerosis. Neurologic Clinics 1996; 14: 399–420
   PubMed Web of Science ®Google Scholar
• Appel V., Stewart S. S., Smith G., Appel S. H. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Annals of Neurology 1987; 22: 328–33
   PubMed Web of Science ®Google Scholar
• Brooks B., Lewis D., Rawling J. The natural history of amyotrophic lateral sclerosis. Motor Neuron Disease, A. C Williams. Chapman & Hall Medical, London 1994; 131–69
   Google Scholar
• Haverkamp L. J., Appel V., Appel S. H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707–19
   PubMed Web of Science ®Google Scholar
• Armon C., Graves M., Moses D., Forte D., Sepulveda L., Darby S., et al. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle and Nerve 2000; 23: 874–82
   PubMed Web of Science ®Google Scholar
• Eisen A., Schulzer M., MacNeil M., Pant B., Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle and Nerve 1993; 16: 27–32
   PubMed Web of Science ®Google Scholar
• Cudkowicz M., Qureshi M., Shefner J. Measures and markers in amyotrophic lateral sclerosis. NeuroRx 2004; 1: 284–94
   PubMedGoogle Scholar
• Gordon P. H., Miller R. G., Moore D. H. ALSFRS‐R. Amyotrophic Lateral Scler Other Motor Neuron Disord 2004; 5((Suppl 1))90–3
   PubMed Web of Science ®Google Scholar
• Stambler N., Charatran M., Cedarbaum J. M. Prognostic indicators of survival in ALS. Neurology 1998; 50: 66–72
   PubMed Web of Science ®Google Scholar
• Cedarbaum J. The amyotrophic lateral sclerosis functional rating scale (ALSFRS). Archives of Neurology 1996; 53: 141–7
   PubMedGoogle Scholar
• Cedarbaum J., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., et al. The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999; 169: 13–21
   PubMed Web of Science ®Google Scholar
• Magnus T., Beck M., Giess R., Puls I., Naumann M., Toyka K. V. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002; 25: 709–14
   PubMed Web of Science ®Google Scholar
• Diggle P., Heagerty P., Liang K., Zeger S. Analysis of longitudinal data. 2nd edn. Oxford University Press, Oxford 2002
   Google Scholar
• McGuire V., Longstreth W. T Jr., Nelson L. M., Koepsell T. D., Checkoway H., Morgan M. S., et al. Occupational exposures and amyotrophic lateral sclerosis. A population‐based case‐control study. American Journal of Epidemiology 1997; 145: 1076–88
   PubMed Web of Science ®Google Scholar
• Horner R., Kamins K., Feussner J., Hoff‐Lindquist J., Harati Y., Mitsumoto H., et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2003; 61: 742–9
   PubMed Web of Science ®Google Scholar
• Kasarskis E., Horner R., Gray K., Feussner J. Amyotrophic lateral sclerosis in military veterans of the Persian Gulf War. Ann Neurol 2002; 52: S96
   Google Scholar
• Kang H. K., Bullman T. A. Mortality among US Veterans of the Persian Gulf War. N Engl J Med 1996; 335: 1498–1504
   PubMed Web of Science ®Google Scholar
• Haley R. Excess incidence of ALS in young Gulf War veterans. Neurology 2003; 61: 750–6
   PubMed Web of Science ®Google Scholar
• Weisskopf M., O'Reilly E., McCullough M. Prospective study of military service and risk of amyotrophic lateral sclerosis. 56th Annual Meeting of the American Academy of Neurology; 2004 April 24–May 1, 2004; San Francisco, California;. 2004; S32.002
   Google Scholar
• Weisskopf M., O'Reilly E., McCullough M., Calle E., Thun M., Cudkowicz M., et al. Prospective study of military service and mortality from ALS. Neurology 2005; 64: 32–7
   PubMed Web of Science ®Google Scholar
• Qureshi M. 2005, Personal Communication with Alberto Ascherio
   Google Scholar
• Ringel S., Murphy J., Alderson M., Bryan W., England J., Miller R., et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 43: 1316–22
   PubMed Web of Science ®Google Scholar
• Gubbay S. S., Kahana E., Zilber N., Cooper G., Leibowitz Y. Amyotrophic lateral sclerosis: a study of its presentation and prognosis. J Neurol 1985; 232: 295–300
   PubMed Web of Science ®Google Scholar
• Mackay R. Course and prognosis in amyotrophic lateral sclerosis. Arch Neurol 1963; 8: 17–27
   Google Scholar
• Rosen A. Amyotrophic lateral sclerosis. Clinical features and prognosis. Archives of Neurology 1978; 35: 638–42
   PubMed Web of Science ®Google Scholar
• Norris F., Shepherd R., Denys E., Mukai E., Elias L., Holden D., et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993; 118: 48–55
   PubMed Web of Science ®Google Scholar
• Schiffer D., Brignolio F., Chio A., Leone M., Rosso M. G. A study of prognostic factors in motor neuron disease. Advances in Experimental Medicine & Biology 1987; 209: 255–63
   PubMedGoogle Scholar
• Thijs V., Peeters E., Theys P., Matthijs G., Robberecht W. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. Acta Neurol Belg 2000; 100: 84–90
   PubMed Web of Science ®Google Scholar
• Chio A., Mora G., Leone M. Early symptom progression rate is related to ALS outcome: prospective population‐based study. Neurology 2002; 59: 99–103
   PubMed Web of Science ®Google Scholar
• Munsat T., Andres P., Finison L., Conlon T., Thibodeau L. The natural history of motor neuron loss in amyotrophic lateral sclerosis. Neurology 1988; 38: 409–13
   PubMed Web of Science ®Google Scholar
• Tysnes O., Vollset S., Aarli J. Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand 1991; 83: 280–5
   PubMed Web of Science ®Google Scholar
• Kasarskis E. J., Ehmann W. D., Markesbery W. R. Trace metals in human neurodegenerative diseases. Progress In Clinical And Biological Research 1993; 380: 299
   PubMedGoogle Scholar
• Felmus M. T., Patten B. M., Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology 1976; 26: 167–72
   PubMed Web of Science ®Google Scholar
• Pierce‐Ruhland R., Patten B. M. Repeat study of antecedent events in motor neuron disease. Ann Clin Res 1981; 13: 102–7
   PubMedGoogle Scholar
• Currier R., Haerer A. Amyotrophic lateral sclerosis and metallic toxins. Archives of Environmental Health 1968; 17: 712–9
   PubMed Web of Science ®Google Scholar
• Conradi S., Ronnevi L., Vesterberg O. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1976; 29: 259–65
   PubMed Web of Science ®Google Scholar
• Kamel F., Umbach D., Munsat T., Shefner J., Hu H., Sandler D. Lead exposure and amyotrophic lateral sclerosis. Epidemiology 2002; 13: 311–9
   PubMed Web of Science ®Google Scholar
• Mitchell J. Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol Clin 1987; 5: 43–60
   PubMedGoogle Scholar
• Mitchell J. Amytrophic lateral sclerosis: toxins and environment. Amyotroph Later Scer Other Motor Neuron Disord 2000; 1: 235–50
   PubMed Web of Science ®Google Scholar
• Qureshi M., Brown R Jr., Cudkowicz M. Metal and ferritin levels in patients with amyotrophic lateral sclerosis (ALS): a retrospective analysis. Annals Neurology 2005; 58: S39
   Google Scholar
• Khare S. S., Ehmann W. D., Kasarskis E. J., Markesbery W. R. Trace element imbalances in amyotrophic lateral sclerosis. Neurotoxicology 1990; 11: 521–32
   PubMedGoogle Scholar
• Strickland D., Smith S., Dolliff G., Goldman L., Roelofs R. Amyotrophic lateral sclerosis and occupational history. A pilot case‐control study. Archives of Neurology 1996; 53: 730–3
   PubMedGoogle Scholar
• Gunnarson L., Lindberg G., Soderfeldt B., Axelson O. Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand 1991; 83: 394–8
   PubMedGoogle Scholar
• Chancellor A., Slattery J., Fraser H., Warlow C. Risk factors for motor neuron disease: a case‐control study based on patients from the Scottish Motor Neuron Disease Register. Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 1200–6
   PubMed Web of Science ®Google Scholar
• Kamel F., Umbach D., Lehman T., Park L., Munsat T., Shefner J., et al. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta‐aminolevulinic acid dehydratase and vitamin D receptor genes. Environmental Health Perspectives 2003; 111: 1335–9
   PubMed Web of Science ®Google Scholar
• Savettieri G., Salemi G., Arcara A., Cassata M., Castiglione M., Fierro B. A case‐control study of amyotrophic lateral sclerosis. Neuroepidemiology 1991; 10: 242–5
   PubMed Web of Science ®Google Scholar
• Granieri E., Carreras M., Tola R., Paolino E., Tralli G., Eleopra R., et al. Motor neuron disease in the province of Ferrara, Italy in 1964–1982. Neurology 1988; 38: 1604–8
   PubMed Web of Science ®Google Scholar
• Deapen D., Henderson B. A case‐control study of amyotrophic lateral sclerosis. American Journal of Epidemiology 1986; 123: 790–9
   PubMed Web of Science ®Google Scholar
• Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339: 1375–7
   PubMed Web of Science ®Google Scholar
• Gough A. C., Miles J. S., Spurr N. K., Moss J. E., Gaedigk A., Eichelbaum M., et al. Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature 1990; 347: 773–6
   PubMed Web of Science ®Google Scholar
• Siddons M. A., Pickering‐Brown S. M., Mann D. M., Owen F., Cooper P. N. Debrisoquine hydroxylase gene polymorphism frequencies in patients with amyotrophic lateral sclerosis. Neuroscience Letters 1996; 208: 65–8
   PubMed Web of Science ®Google Scholar
• Bachus R., Neubert K., Roots I., Prudlo J., Brockmoller J., Ludolph A. C. Polymorphisms of toxifying and detoxifying hepatic enzymes in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003; 74: 1161
   PubMedGoogle Scholar
• Armon C. Epidemiology of amyotrophic lateral sclerosis/motor neuron disease. Motor Neuron Disorders, P Shaw, M Strong. Butterworth Heinemann, Philadelphia 2003; 167–206
   Google Scholar
• Chiò A., Meineri P., Schiffer D., Tribolo A. Risk factors in motor neuron disease: a case control study. Neuroepidemiology 1991; 10: 174–84
   PubMed Web of Science ®Google Scholar
• Cruz D., Nelson L., McGuire V., Longstreth W. Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population based ase‐control study. Neuroepidemiology 1999; 18: 101–10
   PubMed Web of Science ®Google Scholar
• Mandrioli J., Faglioni P., Merelli E., Sola P. The epidemiology of ALS in Modena, Italy. Neurology 2003; 60: 683–9
   PubMed Web of Science ®Google Scholar
• Kurtzke J. F., Beebe G. W. Epidemiology of amyotrophic lateral sclerosis. 1. A case‐control comparison based on ALS deaths. Neurology 1980; 30: 453–62
   PubMed Web of Science ®Google Scholar
• Kondo K., Tsubaki T. Case‐control studies of motor neuron disease. Arch Neurol 1981; 38: 220–6
   PubMed Web of Science ®Google Scholar
• Kamel F., Umbach D., Munsat T., Shefner J., Sandler D. Association of cigarette smoking with ALS. Neuroepidemiology 1999; 18: 194–202
   PubMed Web of Science ®Google Scholar
• Gallagher J., Sanders M. Apparent motor neuron disease following the use of pneumatic tools. Ann Neurol 1983; 14: 694–5
   PubMedGoogle Scholar
• Gallagher J., Talbert O. Motor neuron syndrome after electric shock. Acta Neurol Scand 1991; 83: 79–82
   PubMedGoogle Scholar
• Charles T., Swash M. Amyotrophic lateral sclerosis: current understanding. Journal of Neuroscience Nursing 2001; 33: 245–53
   PubMedGoogle Scholar
• Kurland L. T., Radhakrishnan K., Smith G. E., Armon C., Nemetz P. N. Mechanical trauma as a risk factor in classic amyotrophic lateral sclerosis: lack of epidemiologic evidence. Journal of Neurological Sciences 1992; 113: 133–43
   PubMed Web of Science ®Google Scholar
• Strickland D., Smith S., Dolliff G., Goldman L., Roelofs R. Physical activity, trauma, and ALS: a case‐control study. Acta Neurologica Scandinavica 1996; 94: 45–50
   PubMed Web of Science ®Google Scholar
• Woods A. Trauma as a cause of amyotrophic lateral sclerosis. JAMA 1911; 56: 1876–7
   Google Scholar
• Gallagher J., Sanders M. Trauma and amyotrophic lateral sclerosis: a report of 78 patients. Acta Neurol Scand 1987; 75: 145–50
   PubMed Web of Science ®Google Scholar
• Waggoner R., Lowenberg K. Role of trauma in amyotrophic lateral sclerosis. Arch Neurol Psychiatry 1947; 45: 269–303
   Google Scholar
• Juergens S., Kurland L., Okazaki H., Mulder D. ALS in Rochester, Minnesota, 1925–1977. Neurology 1980; 30: 463–70
   PubMed Web of Science ®Google Scholar
• Riggs J. Trauma and amyotrophic lateral sclerosis. Arch Neurol 1985; 42: 205
   PubMedGoogle Scholar
• Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle & Nerve 1995; 18: 741–52
   PubMed Web of Science ®Google Scholar
• Cleveland D., Rothstein J. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001; 2: 806–19
   PubMed Web of Science ®Google Scholar
• Rothstein J. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Pathogenesis and therapy of amyotrophic lateral sclerosis, G Serratrice, T Munsat. Lippincott‐Raven Publishers, Philadelphia 1995
   Google Scholar
• Rothstein J. D. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clinical Neuroscience 1995; 3: 348–59
   PubMedGoogle Scholar
• Bruijn L. I., Miller T. M., Cleveland D. W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience 2004; 27: 723–49
   PubMed Web of Science ®Google Scholar
• Brown R. H Jr. Amyotrophic lateral sclerosis. Insights from genetics. Archives of Neurology 1997; 54: 1246–50
   PubMed Web of Science ®Google Scholar
• Brown R. H Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687–92
   PubMed Web of Science ®Google Scholar
• Brown R. H., Jr., Robberecht W. Amyotrophic lateral sclerosis: pathogenesis. Seminars in Neurology 2001; 21: 131–9
   PubMed Web of Science ®Google Scholar
• Wong P. C., Rothstein J. D., Price D. L. The genetic and molecular mechanisms of motor neuron disease. Current Opinion in Neurobiology 1998; 8: 791–9
   PubMed Web of Science ®Google Scholar
• Siddique T., Lalani I. Genetic aspects of amyotrophic lateral sclerosis. Neuromuscular Disorders. R Pourmand, Y Harati. Advances in Neurology, Lippincott Williams and Wilkins, Philadelphia 2002; 21–32
   Google Scholar